How a Common Antacid Is Saving Lives in the ICU
-
- 5
The REVISE Trial, involving 4,800 ICU patients, demonstrates that pantoprazole reduces gastrointestinal bleeding risks without affecting mortality rates, influencing future critical care guidelines. A commonly…
Source link
The REVISE Trial, involving 4,800 ICU patients, demonstrates that pantoprazole reduces gastrointestinal bleeding risks without affecting mortality rates, influencing future critical care guidelines. A commonly… Source link
The REVISE Trial, involving 4,800 ICU patients, demonstrates that pantoprazole reduces gastrointestinal bleeding risks without affecting mortality rates, influencing future critical care guidelines. A commonly… Source link